Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14598)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 20, 2017 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Krasimirova E, Velikova T, Ivanova-Todorova E, Tumangelova-Yuzeir K, Kalinova D, Boyadzhieva V, Stoilov N, Yoneva T, Rashkov R, Kyurkchiev D. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients. World J Exp Med 2017; 7(3): 84-96 [PMID: 28890870 DOI: 10.5493/wjem.v7.i3.84] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315x/full/v7/i3/84.htm |
| Number | Citing Articles |
| 1 |
Sambhawana Bhandari, Sadikshya Bhandari, Samikshya Bhandari. Chimeric antigen receptor T cell therapy for the treatment of systemic rheumatic diseases: a comprehensive review of recent literature. Annals of Medicine & Surgery 2023; 85(7): 3512 doi: 10.1097/MS9.0000000000000891
|
| 2 |
Tianlu Li, Lourdes Ortiz-Fernández, Eduardo Andrés-León, Laura Ciudad, Biola M. Javierre, Elena López-Isac, Alfredo Guillén-Del-Castillo, Carmen Pilar Simeón-Aznar, Esteban Ballestar, Javier Martin. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci. Genome Medicine 2020; 12(1) doi: 10.1186/s13073-020-00779-6
|
| 3 |
Sajad Ahmad Dar, Shukla Das, Arshad Jawed, Nighat Nasreen, Gargi Rai. Regulatory T Cells and Autoimmune Diseases. 2024; : 641 doi: 10.1016/B978-0-443-13947-5.00010-5
|
| 4 |
Lazaros I. Sakkas, Theodora Simopoulou. Translational Autoimmunity. 2023; : 447 doi: 10.1016/B978-0-323-85831-1.00022-X
|
| 5 |
Ann‐Helen Rosendahl, Katrin Schönborn, Thomas Krieg. Pathophysiology of systemic sclerosis (scleroderma). The Kaohsiung Journal of Medical Sciences 2022; 38(3): 187 doi: 10.1002/kjm2.12505
|
| 6 |
Miyu Kano, Tadahiro Kobayashi, Mutsumi Date, Momoko Tennichi, Yasuhito Hamaguchi, Daniel S Strasser, Kazuhiko Takehara, Takashi Matsushita. Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37074-9
|
| 7 |
Jie Pan, Fei Dong, Li Ma, Cheng Zhao, Fang Qin, Jing Wen, Wanling Wei, Ling Lei. Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease. Journal of Scleroderma and Related Disorders 2023; 8(3): 231 doi: 10.1177/23971983231180077
|
| 8 |
Yi Lu, Cheng Zhao, Ling Lei, Zhiqing Tao, Leting Zheng, Jing Wen, Xi Li. Effects of thalidomide on Th17, Treg cells and TGF‐β1/Smad3 pathway in a mouse model of systemic sclerosis. International Journal of Rheumatic Diseases 2020; 23(3): 406 doi: 10.1111/1756-185X.13769
|
| 9 |
Zhen Yu, Hao Cheng, Tingting Ding, Yuying Liang, Chenglan Yan, Chong Gao, Hongyan Wen. Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study. Clinical and Experimental Dermatology 2022; 47(12): 2188 doi: 10.1111/ced.15345
|
| 10 |
Satomi Kobayashi, Yasuo Nagafuchi, Hirofumi Shoda, Keishi Fujio. The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic Sclerosis. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.900638
|
| 11 |
Jialing Wu, Xi Zhang, Shen Lin, Qiujing Wei, Zhiming Lin, Ou Jin, Jieruo Gu. Alterations in peripheral T‐ and B‐cell subsets in patients with systemic sclerosis. International Journal of Rheumatic Diseases 2024; 27(4) doi: 10.1111/1756-185X.15145
|
| 12 |
T. Velikova, S. Lazova, P. Perenovska, K. Tumangelova-Yuzeir, D. Miteva, P. Velikov, E. Ivanova-Todorova, D. Kyurkchiev, G. Petrova. Th17 cells in Bulgarian children with chronic obstructive lung diseases. Allergologia et Immunopathologia 2019; 47(3): 227 doi: 10.1016/j.aller.2018.07.004
|
| 13 |
Qiao Wang, Guoshan Shi, Yun Zhang, Feilong Lu, Duoli Xie, Chengping Wen, Lin Huang. Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-36314-2
|
| 14 |
Anouk C. M. Platteel, Bob Meek, Anja Roos. Introductie in de immunologie. Bijblijven 2018; 34(2): 84 doi: 10.1007/s12414-018-0293-7
|
| 15 |
Maria-Cristina Arcangeletti, Clara Maccari, Rosanna Vescovini, Riccardo Volpi, Dilia Giuggioli, Gianluca Sighinolfi, Flora De Conto, Carlo Chezzi, Adriana Calderaro, Clodoveo Ferri. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis. Viruses 2018; 10(9): 508 doi: 10.3390/v10090508
|
| 16 |
M Brown, S O’Reilly. The immunopathogenesis of fibrosis in systemic sclerosis. Clinical and Experimental Immunology 2019; 195(3): 310 doi: 10.1111/cei.13238
|
| 17 |
Se Yun Cheon, Jong Ho Park, Amir H. Ameri, Richard T. Lee, Rosalynn M. Nazarian, Shadmehr Demehri. IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis. Journal of Investigative Dermatology 2022; 142(10): 2668 doi: 10.1016/j.jid.2022.03.009
|
| 18 |
Xinjuan Liu, Yu Wu, Mengtao Li, Jianyu Hao, Qian Wang, Xiaofeng Zeng. Plasticity of Treg and imbalance of Treg/Th17 cells in patients with systemic sclerosis modified by FK506. International Journal of Immunopathology and Pharmacology 2021; 35 doi: 10.1177/2058738421998086
|
| 19 |
Inês S. Silva, Beatriz H. Ferreira, Catarina R. Almeida. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis. Biology 2023; 12(2): 285 doi: 10.3390/biology12020285
|
| 20 |
Nicole Chizara Oparaugo, Kelsey Ouyang, Nam Phuong N. Nguyen, Amanda M. Nelson, George W. Agak. Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers. International Journal of Molecular Sciences 2023; 24(2): 1527 doi: 10.3390/ijms24021527
|
| 21 |
Xiaoyu Cui, Wu Liu, Hanxue Jiang, Qihan Zhao, Yuehong Hu, Xinyue Tang, Xianli Liu, Haoran Dai, Hongliang Rui, Baoli Liu. IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?. Journal of Translational Autoimmunity 2025; 10: 100263 doi: 10.1016/j.jtauto.2024.100263
|
| 22 |
Stefania Nicola, Giovanni Rolla, Caterina Bucca, Giada Geronazzo, Irene Ridolfi, Andrea Ferraris, Enrico Fusaro, Clara Lisa Peroni, Luca Dughera, Luisa Brussino. Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement. Cells 2020; 9(9): 2106 doi: 10.3390/cells9092106
|
| 23 |
Jeffrey C. Y. Yu, Yixiao Zeng, Kaiqiong Zhao, Tianyuan Lu, Kathleen Oros Klein, Inés Colmegna, Maximilien Lora, Sahir R. Bhatnagar, Andrew Leask, Celia M. T. Greenwood, Marie Hudson. Novel insights into systemic sclerosis using a sensitive computational method to analyze whole-genome bisulfite sequencing data. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01513-w
|
| 24 |
Fengyi Xiao, Xishi Liu, Sun-Wei Guo. Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.610963
|
| 25 |
Wei Jin, Yan Zheng, Ping Zhu. T cell abnormalities in systemic sclerosis. Autoimmunity Reviews 2022; 21(11): 103185 doi: 10.1016/j.autrev.2022.103185
|
| 26 |
Camelia Frantz, Cedric Auffray, Jerome Avouac, Yannick Allanore. Regulatory T Cells in Systemic Sclerosis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02356
|
| 27 |
Lisa Göschl, Clemens Scheinecker, Michael Bonelli. Treg cells in autoimmunity: from identification to Treg-based therapies. Seminars in Immunopathology 2019; 41(3): 301 doi: 10.1007/s00281-019-00741-8
|
| 28 |
Di Wang, Ling Lei. Interleukin‐35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases. International Journal of Rheumatic Diseases 2021; 24(1): 21 doi: 10.1111/1756-185X.13962
|
| 29 |
Rosario Foti, Marco Zeppieri, Roberta Foti, Elisa Visalli, Giorgio Amato, Roberta Amato, Edoardo Dammino, Fabiana D’Esposito, Caterina Gagliano. Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis. Journal of Clinical Medicine 2024; 13(10): 2738 doi: 10.3390/jcm13102738
|
| 30 |
Junsuk Ko, Maria Noviani, Vasuki Ranjani Chellamuthu, Salvatore Albani, Andrea Hsiu Ling Low. The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity. International Journal of Molecular Sciences 2023; 24(18): 14287 doi: 10.3390/ijms241814287
|
| 31 |
Steven O’Reilly. Emerging therapeutic targets in systemic sclerosis. Journal of Molecular Medicine 2024; 102(4): 465 doi: 10.1007/s00109-024-02424-w
|